Hao L Y, Kameyama A, Kuroki S, Takano J, Takano E, Maki M, Kameyama M
Department of Physiology, Faculty of Medicine, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima, 890-8520, Japan.
Biochem Biophys Res Commun. 2000 Dec 29;279(3):756-61. doi: 10.1006/bbrc.2000.4040.
We have found previously that L-type Ca2+ channel run-down in cell-free patches is partially (10-28%) reversed by calpastatin (CS) and have suggested that CS, an endogenous inhibitor of calpain, has a Ca2+-channel-regulating function. CS is composed of repetitive domains 1-4 (calpain-inhibitory domain) and domain L (a domain whose function is unknown). We therefore investigated which domain of CS was involved in the regulation of Ca2+ channel activity in guinea pig cardiac myocytes using the patch-clamp technique. After the patches were excised into inside-out mode in basic internal solution, the Ca2+ channel activity ran down to 0.45% of the control level recorded in the cell-attached mode. Application of human recombinant full-length CS (25 microM) and domain L (25 microM) restored the Ca2+ channel activity to 13 and 19% of the control level, respectively, while the channel activity was not restored by CS domain 1 (25 microM) (0.66%). Mouse CS domain XLL (25 microM), a complex of domain XL and domain L, restored the calcium channel activity to 11% of the control level. These results suggested that the Ca2+ channel-regulating function of CS is located in domain L. This study is the first description of the function of CS domain L.
我们之前发现,在无细胞的膜片中,L型钙通道功能衰退的情况有一部分(10%-28%)可被钙蛋白酶抑制蛋白(CS)逆转,并且我们提出,作为钙蛋白酶的一种内源性抑制剂,CS具有钙通道调节功能。CS由重复结构域1-4(钙蛋白酶抑制结构域)和结构域L(一种功能未知的结构域)组成。因此,我们使用膜片钳技术研究了CS的哪个结构域参与豚鼠心肌细胞中钙通道活性的调节。在基本的细胞内溶液中,将膜片切除并转变为内面向外模式后,钙通道活性下降至细胞贴附模式下记录的对照水平的0.45%。应用重组人全长CS(25微摩尔)和结构域L(25微摩尔)分别将钙通道活性恢复至对照水平的13%和19%,而结构域1(25微摩尔)的CS并未恢复通道活性(0.66%)。小鼠CS结构域XLL(25微摩尔),即结构域XL和结构域L的复合物,将钙通道活性恢复至对照水平的11%。这些结果表明,CS的钙通道调节功能位于结构域L。本研究首次描述了CS结构域L的功能。